LifeCycle Pharma Receives US Patent for its MeltDose Technology

18-May-2007

LifeCycle Pharma A/S announced the issuance of a patent for its MeltDose® Technology by the US Patent and Trademark Office, US Patent No. 7,217,431. The patent covers the method of making a particulate material containing a drug substance with low aqueous solubility, using a unique controlled agglomeration process. The issue of the MeltDose® patent does not change the company's financial expectations for 2007.

Other news from the department research and development

More news from our other portals

So close that even
molecules turn red...